Dixon Hubard Feinour & Brown’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Dixon Hubard Feinour & Brown's AMGN Position: Q2 2022 in Review
Dixon Hubard Feinour & Brown increased its Amgen (AMGN) stake by 0.73% in Q2 2022, buying an estimated $8.58K and bringing the position to 4,854 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #136.
Dixon Hubard Feinour & Brown first reported a position in AMGN in Q3 2016 and has held it in 22 quarters since. The position peaked at $6.53M in Q3 2017. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.
- Dixon Hubard Feinour & Brown held 4,854 shares of Amgen worth $1.18M as of Q2 2022.
- Dixon Hubard Feinour & Brown bought 35 Amgen shares in Q2 2022, an estimated $8.58K.
- Amgen made up 0.14% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #136 holding.
- Dixon Hubard Feinour & Brown first reported a position in Amgen in Q3 2016 and has held it in 22 quarters since.
- Dixon Hubard Feinour & Brown's Amgen position peaked at $6.53M in Q3 2017.
- 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.